CVRx | Barostim

CVRx® develops Barostim™ Baroreflex Activation Therapy (BAT), a novel therapy that activates the autonomic nervous system through baroreceptor stimulation to improve the symptoms of heart failure.

Learn more by visiting the following link cvrx.com


 

Drug and Device Therapies to Target the Neurohormonal Cascade

104 views
March 6, 2025
Dr. Mohan discusses the pathophsyiology of heart failure, the challenges and opportunities with contemporary GDMT, Barostim's mechanism of action, and the post-market BeAT-HF trial results.
Comments 0
Login to view comments. Click here to Login